NEXGEL to Present at the H.C. Wainwright 24th Annual Global Investment Conference from September 12-14, 2022
LANGHORNE, Pa., Sept. 07, 2022 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced that Adam Levy, CEO, will present at the H.C. Wainwright 24th Annual Global Investment Conference being held on September 12th – 14th at the Lotte New York Palace Hotel in New York, NY.
H.C. Wainwright 24th Annual Global Investment Conference
Date: Wednesday, September 14, 2022
Time: 9:00 A.M. – 9:30 A.M. Eastern Time
Registration: HERE
If you would like to book 1x1 investor meetings with NEXGEL, please contact your H.C. Wainwright representative or send an email to NEXGEL@kcsa.com.
About NEXGEL, INC.
NEXGEL is a leading provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. Alongside its strategic partners, NEXGEL has formulated more than 200 different combinations to bring natural ingredients to gentle skin patches that can be worn for long periods of time with little to no irritation.
Investor Contacts:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
valter@kcsa.com
Media Contacts:
Raquel Cona
KCSA Strategic Communications
212.896.1204
rcona@kcsa.com
Released September 7, 2022